Remove Conditions Remove Consumption Remove DEA Remove Epilepsy
article thumbnail

Veriheal’s Innovation in Cannabis Scholarship 2020 Winners

Veriheal

Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. This can help change the way people look at the substance. Supply chains are disrupted as a result, and consumers grow fearful of buying hemp.

article thumbnail

What is THC? Here’s everything you need to know

The Cannigma

Marijuana (defined in the US as any cannabis plant where THC>0.3%) is a schedule I drug according to the DEA and FDA. Despite advancements in research, evidence regarding the health effects of cannabis use remains elusive and there is no consensus within the medical community about which conditions it can treat.

THC 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Guest Post: Is CBD Legal? Federal & State Laws [2019]

Cannabis Law Report

Although the DEA refuses to remove marijuana from the schedule 1 list, the Farm Bill is considered to be the most important victory in the history of U.S. If you reside in any of the following 15 states, there are laws stating certain conditions must be met in order to legally obtain CBD.

article thumbnail

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Cannabis Law Report

This differs sharply from the conventional course of cannabis medicine, which is to use whole, clean plant extracts to treat epilepsy and to gradually discontinue use of conventional pharmaceuticals. An Israeli study of cannabis versus epilepsy, however, used natural extracts with a ratio of 20:1 CBD:THC. Lancet Neurol Dec 23 2015.

article thumbnail

GW Pharmaceuticals Wins the Queens Prize for Innovation

SpeedWeed

Rather than going head-to-head with other well-funded competitors in some US state auction while facing down the DEA or buying out a patient collective or two in Canada, the process was a bit simpler. However, for most of its existence, the company produced products not for domestic consumption, but rather for export.